In addition, tumor cells exhibit metabolic heterogeneity, with some leveraging oxidative stress for survival and proliferation, while others over-activate endogenous antioxidant mechanisms, such as GPX4 or NRF2, to resist external antioxidant treatments. Here, NFE2L2 is linked to neoplasm.